Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial
Clinical Research|更新时间:2025-05-15
|
Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial
Chinese Acupuncture & MoxibustionVol. 45, Issue 5, Pages: 627-632(2025)
ZHOU Jie, ZHENG Mengyi, CHEN Shan, et al. Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2025, 45(5): 627-632.
DOI:
ZHOU Jie, ZHENG Mengyi, CHEN Shan, et al. Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial[J]. Chinese Acupuncture & Moxibustion, 2025, 45(5): 627-632.DOI: 10.13703/j.0255-2930.20240322-k0003.
Electroacupuncture at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia with lower urinary tract symptoms: a randomized controlled trial
To observe the clinical efficacy of electroacupuncture (EA) at "four points of sacral region" for mild-to-moderate benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS).
Methods
2
A total of 58 patients with BPH/LUTS were randomly divided into a sacral four-point EA group (29 cases
1 case dropped out) and a conventional EA group (29 cases
1 case dropped out). EA was applied at bilateral points 0.5
cun
lateral to the sacrococcygeal joint and Huiyang (BL35) in the sacral four-point EA group; and was applied at Guanyuan (CV4)
Zhongji (CV3)
Qugu (CV2) and bilateral Shuidao (ST28)
Sanyinjiao (SP6)
Zusanli (ST36) in the conventional EA group. Both groups received continuous wave
2 Hz in frequency
30 min a time
once every other day
3 times a week for 4 weeks. Before treatment
after 2 and 4 weeks of treatment
and in follow-up of 1 month after treatment completion
the international prostate symptom score (IPSS)
the overactive bladder symptom score (OABSS)
the quality of life (QOL) score were observed; before and after treatment
the prostate volume (PV) was measured by abdominal ultrasound; and the clinical efficacy was evaluated after treatment in the two groups.
Results
2
Compared before treatment
the scores of IPSS
OABSS and QOL were decreased after 4 weeks of treatment and in follow-up in both groups (
P
<
0.01
P
<
0.05). In the sacral four-point EA group
the scores of IPSS and QOL after 4 weeks of treatment and in follow-up were lower than those in the conventional EA group (
P
<
0.05
P
<
0.01)
and the OABSS score in follow-up was lower than that in the conventional EA group (
P
<
0.05). After 4 weeks of treatment and in follow-up
the reductions of IPSS and OABSS scores compared before treatment in the sacral four-point EA group were larger than those in the conventional EA group (
P
<
0.01
P
<
0.05); After 2
4 weeks of treatment and in follow-up
the reductions of QOL score compared before treatment in the sacral four-point EA group were larger than those in the conventional EA group (
P
<
0.01). No significant difference in PV was observed after treatment between the two groups (
P
>
0.05). The total effective rate was 75.0% (21/28) in the sacral four-point EA group
which was higher than 39.3% (11/28) in the conventional EA group (
P
<
0.01).
Conclusion
2
EA at "four points of sacral region" can effectively improve the LUTS
overactive bladder symptom and quality of life in patients with mild-to-moderate BPH